Correlation Between Amylyx Pharmaceuticals and Dupont De

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Dupont De at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Dupont De into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Dupont De Nemours, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Dupont De and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Dupont De. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Dupont De.

Diversification Opportunities for Amylyx Pharmaceuticals and Dupont De

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Amylyx and Dupont is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Dupont De Nemours in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dupont De Nemours and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Dupont De. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dupont De Nemours has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Dupont De go up and down completely randomly.

Pair Corralation between Amylyx Pharmaceuticals and Dupont De

Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 3.04 times more return on investment than Dupont De. However, Amylyx Pharmaceuticals is 3.04 times more volatile than Dupont De Nemours. It trades about 0.23 of its potential returns per unit of risk. Dupont De Nemours is currently generating about 0.15 per unit of risk. If you would invest  818.00  in Amylyx Pharmaceuticals on June 6, 2025 and sell it today you would earn a total of  177.00  from holding Amylyx Pharmaceuticals or generate 21.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Amylyx Pharmaceuticals  vs.  Dupont De Nemours

 Performance 
       Timeline  
Amylyx Pharmaceuticals 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Dupont De Nemours 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Dupont De Nemours are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Dupont De exhibited solid returns over the last few months and may actually be approaching a breakup point.

Amylyx Pharmaceuticals and Dupont De Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amylyx Pharmaceuticals and Dupont De

The main advantage of trading using opposite Amylyx Pharmaceuticals and Dupont De positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Dupont De can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dupont De will offset losses from the drop in Dupont De's long position.
The idea behind Amylyx Pharmaceuticals and Dupont De Nemours pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years